Antibacterial drugs are important to treat infections. But increasing bacterial resistance to current drugs — making them ineffective or only partially effective — means that new ones are urgently needed. Building on...
The annual World Antimicrobial Resistance Awareness Week (WAAW) is a global campaign to draw attention to the dangers of antimicrobial resistance (AMR). It also aims to inform people about behaviors that can reduce the...
Professors Ivo Boneca (Institut Pasteur, Paris), Mark Brönstrup (Helmholtz Centre for Infection Research, Braunschweig), and Christophe Zimmer (University of Würzburg) have jointly been awarded one of the most...
The Helmholtz Association has appointed internationally respected US-based scientist Martin Keller as its new president. Following a unanimous vote by the Assembly of Members last Wednesday, the Helmholtz Senate...
The Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) is growing: In the past three years, the institute – a site of the Helmholtz Centre for Infection Research (HZI) in collaboration with Saarland...
Our immune system successfully defends itself against pathogens on a daily basis - often without us realizing it. We notice other encounters with pathogens through cold symptoms, fever or a red, swollen area. Our immune...
Prof. Josef Penninger, Scientific Director of the Helmholtz Centre for Infection Research (HZI) in Braunschweig, has been appointed honorary professor of the Faculty of Life Sciences at Technische Universität...
Colistin is a last-resort antibiotic that is usually only used for severe infections with resistant bacteria. This is due to its severe kidney-damaging side effects, which occur in around 30 percent of treated patients....
According to the WHO, antimicrobial resistance (AMR) is one of the ten greatest threats to global health. In the EU alone, around 35,000 people die every year from antibiotic-resistant infections. The WHO estimates that...